Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.509 SEK | 0.00% |
|
-1.55% | +11.50% |
22/05 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
22/05 | Active Biotech Enters into an Exclusive License Agreement with the Wistar Institute of Anatomy and Biology | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.50% | 17.66M | |
+14.84% | 121B | |
+18.31% | 112B | |
+2.94% | 22.57B | |
-18.26% | 20.82B | |
-18.47% | 16.19B | |
-42.36% | 16.17B | |
-14.23% | 16.3B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- ACTI Stock
- News Active Biotech AB
- Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug